Alerus Financial’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4K | Buy |
+1,000
| New | +$10.4K | ﹤0.01% | 359 |
|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$19.5K | – | 167 |
|
|
2024
Q1 | $19.5K | Hold |
1,000
| – | – | ﹤0.01% | 161 |
|
|
2023
Q4 | $20.7K | Hold |
1,000
| – | – | ﹤0.01% | 149 |
|
|
2023
Q3 | $31.8K | Hold |
1,000
| – | – | ﹤0.01% | 150 |
|
|
2023
Q2 | $33.6K | Hold |
1,000
| – | – | ﹤0.01% | 155 |
|
|
2023
Q1 | $41.7K | Hold |
1,000
| – | – | ﹤0.01% | 161 |
|
|
2022
Q4 | $33.9K | Hold |
1,000
| – | – | ﹤0.01% | 160 |
|
|
2022
Q3 | $49K | Hold |
1,000
| – | – | ﹤0.01% | 147 |
|
|
2022
Q2 | $39K | Buy |
1,000
+667
| +200% | +$26K | ﹤0.01% | 162 |
|
|
2022
Q1 | $12K | Hold |
333
| – | – | ﹤0.01% | 178 |
|
|
2021
Q4 | $33K | Hold |
333
| – | – | ﹤0.01% | 182 |
|
|
2021
Q3 | $42K | Hold |
333
| – | – | ﹤0.01% | 181 |
|
|
2021
Q2 | $42K | Hold |
333
| – | – | ﹤0.01% | 190 |
|
|
2021
Q1 | $45K | Buy |
+333
| New | +$45K | ﹤0.01% | 184 |
|